top of page

MSKCC Second Opinion Paused? How to Secure a Second Opinion from Top 5 U.S. Cancer Specialist 2026

Updated: Mar 5


Published by: Medebound HEALTH

Reading Time: 6 minutes


Table of Content:


Cancer patients often seek second opinions to confirm diagnoses, explore treatment options, and gain peace of mind. Memorial Sloan Kettering Cancer Center (MSKCC) has long been a trusted source for expert second opinions, especially through its remote consultation services.


However, as of November 2025, MSKCC has officially paused its remote second opinion program. This change leaves many patients wondering how to proceed with obtaining a reliable second opinion without traveling or facing delays.


This article guides you through the current landscape of cancer second opinions, explains why they matter, and outlines practical ways international families can obtain collaborative second opinion insights and educational guidance through structured consultation programs such as Medebound HEALTH..


If you are searching for MSKCC second opinion and its associated cost, this post will help you navigate your options and continue your cancer care journey with confidence.




Why a Second Opinion Matters in Cancer Care


Cancer treatment decisions are complex and deeply personal. A second opinion can:


  • Confirm the accuracy of your diagnosis;

  • Present additional treatment options you might not have considered

  • Provide reassurance about your current treatment plan; Help you understand potential side effects and outcomes


Research shows that second opinions can lead to changes in diagnosis or treatment plans in up to 60% of cases. This can improve outcomes and reduce unnecessary procedures. Given the stakes, having access to expert advice is crucial.


Memorial Sloan Kettering’s remote second opinion service was a popular choice because it allowed patients to receive expert input from world-class oncologists without requiring travel. With this service paused, many patients—especially international families—are now exploring alternative ways to obtain similar expert insight and convenience.



What Happened to MSKCC’s Remote Second Opinion Program?


As of November 2025, several leading U.S. cancer centers have adjusted their remote consultation services. Many top institutions, including Memorial Sloan Kettering and MD Anderson Cancer Center, now primarily focus on in-person consultations at their facilities.


What This Means for Patients:

While institutional remote programs at some top cancer centers have been paused or adjusted, in-person second opinions remain fully available at these world-class facilities. If your health condition allows for travel, you can still visit these institutions for comprehensive onsite consultations.


However, not all patients—particularly international patients can travel, and in-person visits involve considerations such as:

  • Health conditions that make long-distance travel challenging

  • Time constraints when treatment decisions cannot wait

  • International travel costs, visa requirements, and logistics

  • Physical and emotional strain of extended travel during treatment


If MSKCC Paused Its Remote Second Opinion Right Now, What Can You Do?


  1. Contact MSK Directly (If You Can Travel)

MSKCC still offers in-person second opinions through its direct program, and some services may be available for certain insured patients within the U.S. Always check your insurance coverage because some may not accept your current insurance.


  1. Seek Second Opinions from Other Top U.S. Cancer Centers


Other top cancer hospitals such as MD Anderson (ranked #1 in the nation in cancer care), is also well known for  its on-site second opinion program. Unfortunately, currently they do not offer remote second opinions as well (only in-person second opinion that can be frequently quoted for~ $30,000 with travel and lodging).


  1. Medebound HEALTH:  Expert Consultation Supporting Your Care Team

This is where Medebound HEALTH fits in — especially for international patients and families seeking clarity before making major treatment or travel decisions.


Medebound HEALTH facilitates collaborative second opinions through a structured peer-to-peer consultation model, allowing international cases to be reviewed by U.S.-licensed cancer specialists with experience or professional appointments at leading cancer centers such as MSK, MD Anderson, and Dana-Farber.

Important: All consultations are conducted by independent U.S.-licensed physicians and are not services of any hospital or cancer center as an institution.


Medebound HEALTH’s role is to provide a physician-to-physician educational consultation that may offer additional insights the patient’s care team can review. Any decisions about treatment or next steps should be made together with patient’s local treating doctors.


Why This Matters for YOU

For many families exploring expert cancer care in the United States, there are generally two stages in the process: gaining clarity about the case and pursuing a formal institutional consultation.


Traditional top 5 U.S. cancer centers in-person second opinion:

An in-person consultation at a leading cancer center provides direct evaluation within the hospital system. For international patients, this process typically involves travel planning and logistical coordination.


Typical considerations may include:

  • Round-trip international/domestic flights and lodging in the U.S. for ~2 weeks: $3,500–$9,000

  • Meals and local transportation for ~2 weeks: $800–$1,500

  • On-site second opinion consultation and diagnostic review: approximately $8,000–$30,000 (treatment not included)

Estimated total investment: $12,500–$40,000


For patients who are medically able to travel and ready to pursue institutional evaluation, this pathway allows them to receive care directly within the hospital.

 

Structured Case Review from independent physicians trained or currently at MSKCC, MD Anderson, or other leading cancer center through Medebound HEALTH:


Before committing to international travel, some families prefer to first gain clarity about their diagnosis, treatment options, and whether pursuing evaluation at a U.S. cancer center would be appropriate.


Through Medebound HEALTH, patients can request a physician case review and educational consultation with independent U.S.-licensed physicians, many of whom trained or have experience at leading cancer centers such as MSK, MD Anderson, or Dana-Farber.


This stage can help families:

  • Organize and review their medical records

  • Understand potential treatment considerations

  • Discuss questions with their local physicians

  • Decide whether pursuing a formal in-person consultation at a U.S. cancer center would be beneficial


Typical cost for this type of physician review and consultation: $2,000–$6,000 depending on case complexity, with no travel or lodging expenses required.





Case Spotlight: Ms. Wu’s Journey with a Cancer Specialist Currently Practices at MSKCC for a Second Opinion

The Patient

"Ms. Wu" (pseudonym), diagnosed with Stage IVB endometrial serous carcinoma, was facing recurrence following surgery. Her domestic care team was managing the condition, but the significant side effects of the current regimen were creating a serious quality-of-life burden — raising clinical questions that local expertise alone could not fully resolve.

Her treating physician recognized a dual clinical challenge: ensuring treatment efficacy while identifying whether better-tolerated alternatives existed, and whether emerging U.S. therapies could offer a more sustainable long-term path.



The Clinical Need

Ms. Wu's treating physician sought a collaborative consultation with a U.S.-based specialist in advanced gynecologic oncology — specifically one with dedicated expertise in endometrial serous carcinoma and its molecular subtypes, including PI3K pathway mutations and HER2-positive disease.


Medebound HEALTH facilitated this cross-border second opinion, connecting Ms. Wu's physician directly with "Dr. Evelyn" (pseudonym), a gynecologic oncologist and endometrial cancer program lead with a professional appointment at Memorial Sloan Kettering Cancer Center (MSKCC), New York — one of the top-ranked cancer centers in the United States and a designated NCI Comprehensive Cancer Center.



How The U.S. Expert Communicated with The Case Physician

A structured video consultation was conducted following Dr. Evelyn's thorough review of Ms. Wu's translated medical records, genomic profile, and full treatment history. The clinical exchange centered on two key areas identified through the discussion:

  • The availability of a more evidence-aligned first-line regimen with built-in tolerability flexibility

  • A clearly mapped progression of advanced U.S. therapeutic options informed by Ms. Wu's specific molecular profile



The Clinical Direction Established

Through discussion with care team, Dr. Evelyn shared her clinical perspective on a staged, molecularly informed treatment framework:

  • Optimized first-line regimen: A four-drug combination — nab-paclitaxel + carboplatin + bevacizumab + pembrolizumab — reflecting the latest clinical evidence for advanced endometrial serous carcinoma

  • Tolerability management: Dose adjustments to nab-paclitaxel and carboplatin could be made without compromising the overall treatment framework — directly addressing the quality-of-life concern at the center of the consultation

  • Future therapeutic options: Ms. Wu's genomic profile — including PI3K pathway mutations and HER2-positive status — opens pathways to multiple innovative U.S. therapies with demonstrated efficacy in controlling tumor progression while minimizing toxicity

  • Clinical trial access: Active U.S. research in these molecular subtypes means viable trial options remain available as a downstream safety net


This clinical knowledge — exchanged specialist to specialist — gave Ms. Wu's treating physician an evidence-based framework to meaningfully refine the local care strategy.



The Outcome

Through the collaboration between doctor in US and local care team, Ms. Wu's treating physician was equipped with both a refined treatment direction and a clearly mapped progression of future options — filling a critical gap that the domestic care pathway had not addressed.

"I now have a clear plan that accounts for how I'm feeling, not just the tumor. Knowing there are still options ahead makes a real difference." — Ms. Wu, relayed through her treating physician

Her care team noted that the combination of an optimized regimen, a built-in side effect management strategy, and a structured progression of future options represented exactly the clinical guidance the case had been missing.



Key Takeaway

This case illustrates that physician-to-physician educational consultation is not always about finding a completely different treatment — sometimes it is about refining the approach, managing tolerability, and ensuring the treating physician has a clear clinical roadmap for what comes next. For complex, recurrent gynecologic cancers, connecting a treating physician with a U.S. specialist leading a dedicated disease program can reframe both the clinical strategy and the patient's confidence in facing it.


An independent U.S.-licensed oncologist with a faculty appointment at MSKCC provides a virtual physician consultation to Ms. Wu’s case physician through Medebound HEALTH’s case review program. Photos and names are anonymized to protect patient privacy and confidentiality.
An independent U.S.-licensed oncologist with a faculty appointment at MSKCC provides a virtual physician consultation to Ms. Wu’s case physician through Medebound HEALTH’s case review program. Photos and names are anonymized to protect patient privacy and confidentiality.



Here’s how it works:

Fast Turnaround

Most consultative case reviews are completed within 5–7 days after complete medical records are received — allowing families to obtain expert educational guidance before making major treatment or travel decisions


Expert Matching

Medebound HEALTH helps organize your case and coordinate review with independent U.S.-licensed oncologists who are active or trained at top U.S. cancer centers.

The case is prepared and presented so the consulting physician can provide educational consultation based on the specific cancer type and treatment considerations


Language & Navigation Support

For many international patients, language barriers are a major obstacle. Medebound HEALTH provides professional translation and coordination so nothing is lost in communication.


Written & Collaborative Video Consultation

You can choose between:

  • A detailed written physician consult memo summarizing expert educational guidance and treatment considerations, or 

  • A collaborative video consultation, where the consulting U.S. physician discusses the case with the patient’s local or case physician in a structured educational format.


This process allows international families to gain clarity on potential treatment options while continuing to work with their local medical team.


What International Patients Can Do Next


If you were planning to use MSKCC’s or another top U.S. cancer center’s remote second opinion service, it may still be helpful to begin by organizing your medical records and discussing next steps with your local care team

 

For many international families, gaining additional expert perspective before making major travel or treatment decisions can be valuable. Programs such as Medebound HEALTH help patients prepare their case for independent physician educational consultation, making it easier to obtain insights from experienced U.S. specialists.


Medebound HEALTH assists with record collection, case organization, and coordination, allowing an independent U.S.-licensed oncologist to review the case and provide consultative educational input that can be shared with your local doctors.


Cancer care often benefits from multiple perspectives. Educational consultations with experienced specialists can help patients and their local physicians explore potential options and considerations before determining the most appropriate next steps.


For international patients who may later pursue care at a U.S. cancer center, this type of consultation can also help families better understand whether a formal institutional evaluation or travel for treatment may be appropriate.


About Medebound HEALTH:

Since 2016, Medebound HEALTH has helped thousands of international families — mostly from Asia — get independent physician educational consultations with experienced U.S.-licensed oncologists.


These physicians have training or professional experience at leading U.S. cancer centers such as Memorial Sloan Kettering, MD Anderson Cancer Center, Mayo Clinic, and Johns Hopkins. Through written expert review or collaborative video consultation, physicians provide structured educational insight that patients can share with their local medical teams.


Medebound HEALTH supports the process by assisting with medical record organization, specialist matching, and cross-border coordination, helping families better understand potential options before considering formal evaluation or treatment at major cancer centers.


Contact Us to Get Started

Submit the form:  Click  HERE we will get back within 4 hours

Free-toll US Phone Number: +1 917 342 2381

Instant Chat: Click the chat button at the lower right corner of this page👇


Disclaimer

We strive to maintain the accuracy and provide regular updates for the treatment information described in this article. However, treatment outcomes may vary between individuals. The information provided here is not intended as a diagnostic or treatment recommendation and should not replace the careful evaluation and advice of your attending physician. The service is independently operated by Medebound HEALTH and is not provided, partnered, or affiliated with any hospital center as an institution.


Make Inquiries Now
If you or your loved ones would like to consult a top specialist in the US or consider traveling for care 

Thank You For Submitting. We will get back to you shortly.

Why Medebound HEALTH

1000+ US Physician Network

We know top doctors make a difference. Our consulting doctors are world-class physicians recognized by prestigious awards such as Castle Connolly Top Doctors, encompassing 70+ medical disciplines representing the Top 1% doctors of in the nation.

Top 20 US Hospitals

 Medebound HEALTH sends cases to the top doctors from the best medical institutions. These doctors are trained and teaching at top research hospitals, pioneering cutting-edge research, and advocating groundbreaking treatment regimens. 90% of our doctors are trained and worked at some of the country’s most elite institutions, such as Johns Hopkins Hospital, Boston Children’s Hospital, and the Hospital for Special Surgery.

Medebound HEALTH

US Operation

Site Click HERE
260 Madison Ave 8th Floor #8001
New York, NY 10016

support@medeboundhealth.com
+1 917 342 2381

Asia Operation

 

 Site Click HERE

Champiom Building #810A,301-309 Nathan Rd,  HongKong

support@medebound.com
+86 400-616-2591

Disclaimer: Medebound HEALTH provides informational services only. Second opinions are provided solely for informational, educational, and reference purposes and are not intended to establish a physician-patient relationship. All patients have acknowledged this in writing.  All consultations are provided by independent U.S.-licensed physicians. This service is not provided, endorsed, or affiliated with any hospital as an institution.

  • X
  • Instagram
  • LinkedIn
  • Facebook

©2026 by Medebound HEALTH

bottom of page